Factors Involved in the Pathogenesis of HLA-B27 Associated Arthritis

References

• Linssen A, Feltkamp T EW. B27 positive diseases versus B27 negative diseases. Ann Rheum Dis 1988; 47: 431–9
   PubMedGoogle Scholar
• van der Linden J MJP, Valkenburg H A, De Jong B A, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1984; 27: 241–9
   PubMed Web of Science ®Google Scholar
• Linssen A, Rothova A, Valkenburg H A, Dekker-Saeys A J, Luyendijk L, Kijlstra A, Feltkamp T EW. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 1991; 32: 2568–78
   PubMed Web of Science ®Google Scholar
• Derhaag P JFM, Linssen A, Broekema N, De Waal L P, Feltkamp T EW. A family study of the inheritance of HLA-B27 positive acute anterior uveitis. Am J Ophthalmol 1988; 105: 603–6
   PubMed Web of Science ®Google Scholar
• Breur-Vriesendorp B S, Dekker-Saeys A J, Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: The disease is associated with a common determinant of various B27 molecules. Ann Rheum Dis 1987; 46: 353–6
   PubMedGoogle Scholar
• Derhaag P JFM, De Waal L P Linssen. Feltkamp TEW. Acute anterior uveitis and HLA-B27 subtypes. Invest Ophthalmol Vis Sci 1988; 29: 1137–40
   PubMedGoogle Scholar
• Robinson W P, van der Linden S M, Khan M A, Rentsch H-U, Cats A, Russell A, Thomson G. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum 1989; 32: 1135–41
   PubMed Web of Science ®Google Scholar
• Derhaag P JFM, van der Horst A R, De Waal L P, Feltkamp T EW. HLA-B27+ acute anterior uveitis and other antigens of the major histocompatibility complex. Invest Ophthalmol Vis Sci 1989; 30: 2160–4
   PubMed Web of Science ®Google Scholar
• Lochead J A, Chalmers I M, Marshall W H, Larsen B, Skanes V M, Payne R H, Barnard JM. HLA-B27 haplo-types in family studies of ankylosing spondylitis. Arthritis Rheum 1983; 26: 1011–6
   PubMedGoogle Scholar
• Verjans G MGM, van der Linden S M, Van Eys G JJM, De Waal L P, Kijlstra A. Restriction fragment length polymorphism of the tumor necrosis factor region in patients with ankylosing spondylitis. Arthritis Rheum 1991; 34: 486–9
   PubMedGoogle Scholar
• Verjans G MGM, Messed G, Weiss E H, Van der Linden, Kijlstra A. Polymorphism of the tumor necrosis factor region in relation to disease: an overview. Rheum Dis Clin North Am 1992; 18: 177–86
   PubMedGoogle Scholar
• Linssen A, Rothova A, Broekema N, Derhaag P JFM, Luyendijk L, De Lange G G, et al. Genes on the chromosome 14q and their role in the pathogenesis of HLA-B27 associated diseases. Clin Exp Rheumatol 1987s; 89–95, S Suppl. 1
   PubMedGoogle Scholar
• De Jongh B M, van der Linden S M, Volkers W S, Cats A. Genetics of non-HLA marker genes in HLA B27-positive and -negative ankylosing spondylitis families. Scand J Rheumatol 1990; 87: 127–30, Suppl
   Google Scholar
• Feltkamp T EW. New views on B27 associated diseases. Neth J Med 1989; 35: 119–22
   PubMedGoogle Scholar
• Madden D R, Gorga J C, Strominger J L, Wiley DC. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991; 353: 321–5
   PubMed Web of Science ®Google Scholar
• Verjans G MGM, Van Alphen L, Feltkamp T EW. Invasie en replicatie van Salmonella typhimurium en Yersinia en-terocolitica in humane mononucleaire cellen. Ned Tijd-schr Geneeskd 1993; 137: 687–8
   Google Scholar
• Hermann E, Yu D TY, Meyer zum Büschenfelde K-H, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993; 342: 646–50
   PubMed Web of Science ®Google Scholar
• Streilein J W, Wilbanks G A, Taylor A, Cousins S. Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review. Curr Eye Res 1992; 11: 41–7, Suppl
   PubMed Web of Science ®Google Scholar
• Shull M M, Hsby I, Kier A B, Pawlowski S, Diebold R J, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annun-Ziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693–9
   PubMed Web of Science ®Google Scholar
• Van Beuningen H M, van der Kraan P M, Amtz O J, Van den Berg WB. Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies ion anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 1993; 52: 185–91
   PubMed Web of Science ®Google Scholar
• Thorbecke G J, Shah R, Leu C H, Kuruvilla A P, Hardinson A M, Palladino MA. Involvement of endogenous tumor necrosis factor and transforming growth factor β during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 1992; 89: 7375–9
   PubMed Web of Science ®Google Scholar
• Wahl S M, Allen J B, Costa G L, Wong H L, Dasch JR. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta. J Exp Med 1993; 177: 225–30
   PubMed Web of Science ®Google Scholar
• Taylor H G, Weiss J B, McLaughlin B, Dawes FT. Raised endothelial cell stimulating angiogenesis factor in anky-losing spondylitis. Clin Exp Rheumatol 1993; 11: 537–9
   PubMedGoogle Scholar